Table 2.
exposure () | Guatemala | India | Peru | Rwanda | Overall | |||||
---|---|---|---|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | |
Baseline | ||||||||||
Enrolled participants | 400 | 400 | 399 | 400 | 402 | 396 | 404 | 394 | 1,605 | 1,590 |
n (% of enrolled) | 373 (93) | 360 (90) | 358 (90) | 357 (89) | 327 (81) | 331 (84) | 364 (90) | 353 (90) | 1,422 (89) | 1,401 (88) |
Range | 10.5–1,799 | 9.9–780.3 | 10.8–1,033.9 | 9.4–2,099.9 | 10.7–697.1 | 11.0–1,400.1 | 14.3–1,089.8 | 14.2–865.6 | 10.5–1,799 | 9.4–2,099.9 |
Median (IQR) | 110.2 (63.3–176) | 122.3 (65.8–200.2) | 73.8 (46.7–123.3) | 78.4 (47.9–142.9) | 46.1 (15.2–108.5) | 53.3 (22.8–111.2) |
94 (58.6–144.8) |
82.7 (47.8–134.1) | 83.1 (45.9–141.4) | 81.7 (45.9–150.8) |
Postintervention visit 1 | ||||||||||
Enrolled participants | 396 | 398 | 394 | 393 | 387 | 390 | 403 | 388 | 1,580 | 1,569 |
n (% of enrolled) | 339 (86) | 361 (91) | 311 (79) | 314 (80) | 269 (70) | 289 (74) | 332 (82) | 321 (83) | 1,251 (79) | 1,285 (82) |
Range | 9.9–681.7 | 9.6–459 | 10.5–890.3 | 10.4–300.8 | 9.9–1,116.8 | 9.6–258.8 | 14–1,093 | 14.2–283.9 | 9.9–1,116.8 | 9.6–459 |
Median (IQR) | 98.4 (58.7–164.7) | 23.3 (14.9–36.2) | 67.3 (38.9–117.8) | 28.7 (16.9–45.5) | 31.4 (14.5–74.4) | 14.6 (14.1–23.1) | 79.6 (48.5–129.6) |
33.6 (23.8–50) |
71.5 (38.5–125.9) | 24.1 (15.0–39.5) |
Postintervention visit 2 | ||||||||||
Enrolled participants | 392 | 391 | 390 | 391 | 368 | 385 | 401 | 385 | 1,551 | 1,552 |
n (% of enrolled) | 317 (81) | 330 (84) | 284 (73) | 293 (75) | 219 (60) | 264 (69) | 318 (79) | 289 (75) | 1,138 (73) | 1,176 (76) |
Range | 10.3–689.3 | 9.7–441.8 | 10.4–793.8 | 5.7–462.5 | 10.2–1,208.4 | 10.5–850.8 | 14.6–664.7 | 12.5–751.7 | 10.2–1,208.4 | 5.7–850.8 |
Median (IQR) | 93.6 (53.6–168.2) | 23.8 (16.3–38.5) | 68.2 (36.3–129.3) | 25.3 (16.9–41.8) | 24.7 (14.5–57.9) | 14.6 (13.9–18.6) | 79.9 (45.9–128.1) | 28.2 (23.6–49.1) | 69.5 (36.5–130.8) | 23.7 (14.9–39.7) |
BC exposure () | Guatemala | India | Peru | Rwanda | Overall | |||||
---|---|---|---|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | |
Baseline | ||||||||||
Enrolled participants | 400 | 400 | 399 | 400 | 402 | 396 | 404 | 394 | 1,605 | 1,590 |
n (% of enrolled) | 343 (86) | 332 (83) | 351 (88) | 348 (87) | 289 (72) | 307 (78) | 289 (72) | 280 (71) | 1,272 (79) | 1,267 (80) |
Range | 2.5–95.6 | 2.6–132.6 | 0.7–73.2 | 0.6–102.7 | 1.5–74.9 | 1.5–75.3 | 2.7–70.4 | 2.7–76.9 | 0.7–95.6 | 0.6–132.6 |
Median (IQR) | 12.1 (9.1–15.3) | 11.7 (9.4–14.8) | 9.4 (5.5–15.7) | 9.8 (5.5–16.4) | 7.9 (2.3–15.7) | 8.7 (3.6–15.5) | 11.8 (8.3–15.6) | 9.7 (6.6–14.2) | 10.8 (6.8–15.5) | 10.5 (6.2–15.3) |
Postintervention visit 1 | ||||||||||
Enrolled participants | 396 | 398 | 394 | 393 | 387 | 390 | 403 | 388 | 1,580 | 1,569 |
n (% of enrolled) | 330 (83) | 359 (90) | 304 (77) | 305 (78) | 246 (64) | 268 (69) | 307 (76) | 294 (76) | 1,187 (75) | 1,226 (78) |
Range | 2.6–52.9 | 2.2–131.5 | 0.7–98.5 | 0.7–44.6 | 1.4–73.6 | 1.4–13.8 | 2.8–122 | 2.6–54.7 | 0.7–122 | 0.7–131.5 |
Median (IQR) | 11.5 (8.1–15.1) | 2.7 (2.6–5.3) | 8.9 (4.5–14.5) | 2.1 (1.1–3.6) | 4.4 (1.6–12.1) | 1.6 (1.5–1.6) | 10 (7–13.9) | 4.2 (2.9–5.9) | 9.7 (5.3–14.4) | 2.7 (1.6–4.7) |
Postintervention visit 2 | ||||||||||
Enrolled participants | 392 | 391 | 390 | 391 | 368 | 385 | 401 | 385 | 1,551 | 1,552 |
n (% of enrolled) | 310 (79) | 326 (83) | 277 (71) | 289 (74) | 201 (55) | 242 (63) | 291 (73) | 277 (72) | 1,079 (70) | 1,134 (73) |
Range | 2.5–88.1 | 2.5–64.8 | 0.7–97.8 | 0.6–105.2 | 1.3–123.5 | 1.4–14.5 | 2.8–61.5 | 2.5–44 | 0.7–123.5 | 0.6–105.2 |
Median (IQR) | 11.1 (8.4–14.5) | 2.9 (2.6–5.7) | 8.2 (4.4–14) | 2.5 (1.5–4.1) | 3.7 (1.6–10.8) | 1.6 (1.5–1.6) | 10.3 (6.4–13.7) | 3.8 (2.9–6.2) | 9.6 (5.2–13.7) | 2.8 (1.7–4.8) |
CO exposure (ppm) | Guatemala | India | Peru | Rwanda | Overall | |||||
---|---|---|---|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | |
Baseline | ||||||||||
Enrolled participants | 400 | 400 | 399 | 400 | 402 | 396 | 404 | 394 | 1,605 | 1,590 |
n (% of enrolled) | 382 (96) | 375 (94) | 372 (93) | 373 (93) | 333 (83) | 326 (82) | 360 (89) | 356 (90) | 1,447 (90) | 1,430 (90) |
Range | 0.0–60.2 | 0.0–21.7 | 0.0–46.9 | 0.0–31.6 | 0.0–54.3 | 0.0–69.5 | 0.0–29.6 | 0.0–44.4 | 0.0–60.2 | 0.0–69.5 |
Median (IQR) | 1.3 (0.5–2.5) | 1.4 (0.6–2.8) | 0.8 (0.3–1.9) | 0.9 (0.3–2.1) | 1.9 (0.7–4.3) | 1.9 (0.8–4.8) | 1.1 (0.5–2.0) | 1.2 (0.5–3.0) | 1.2 (0.5–2.5) | 1.3 (0.5–3.0) |
Postintervention visit 1 | ||||||||||
Enrolled participants | 396 | 398 | 394 | 393 | 387 | 390 | 403 | 388 | 1,580 | 1,569 |
n (% of enrolled) | 355 (90) | 363 (91) | 352 (89) | 347 (88) | 269 (70) | 264 (68) | 335 (83) | 341 (88) | 1,311 (83) | 1,315 (84) |
Range | 0.0–21.7 | 0.0–11.9 | 0.0–24.7 | 0.0–17.3 | 0.0–64.2 | 0.0–23.9 | 0.0–25.9 | 0.0–9.3 | 0.0–64.2 | 0.0–23.9 |
Median (IQR) | 1.2 (0.5–2.5) | 0.1 (0–0.5) | 0.8 (0.2–2.1) | 0 (0–0.3) | 1.2 (0.3–3.4) | 0.7 (0.2–1.8) | 1 (0.4–2.1) | 0.2 (0.1–0.7) | 1.1 (0.4–2.5) | 0.2 (0–0.7) |
Postintervention visit 2 | ||||||||||
Enrolled participants | 392 | 391 | 390 | 391 | 368 | 385 | 401 | 385 | 1,551 | 1,552 |
n (% of enrolled) | 336 (86) | 344 (88) | 320 (82) | 313 (80) | 212 (58) | 250 (65) | 345 (86) | 320 (83) | 1,213 (78) | 1,227 (79) |
Range | 0.0–14.4 | 0.0–8.9 | 0.0–35.9 | 0.0–6.9 | 0.0–43.7 | 0.0–21.2 | 0.0–26.4 | 0.0–6.7 | 0.0–43.7 | 0.0–21.2 |
Median (IQR) | 1.2 (0.4–2.2) | 0.2 (0–0.6) | 0.7 (0.1–2.2) | 0 (0–0.2) | 1.5 (0.5–3.3) | 0.6 (0.1–1.3) | 1.1 (0.4–2.2) | 0.2 (0.1–0.7) | 1.1 (0.3–2.3) | 0.2 (0–0.7) |
Note: “Enrolled participants” are the number of pregnant women participating in each IRC and treatment arm at each measurement round. Deviations from the overall number of participants at baseline are due to study exits. In addition, “n” is the number of valid, nonmissing measurements by IRC, treatment arm, and measurement round. “% of enrolled” is “n”/“Enrolled participants.” BC, black carbon; CO, carbon monoxide; IQR, interquartile range; SD, standard deviation.